Review of Savaria Corporation

SEP 05, 2024 - Savaria Corporation (SIS) is a global leader in the accessibility industry, providing solutions for the seniors and individuals with disabilities. IS has one of the industry’s most comprehensive product lines aimed at improving the comfort, mobility, and independence of its target market. As the company continues to implement initiatives under Savaria One we think the growth story is easy story for investors to get behind. We are maintaining our rating of a B+ and have a positive mid-term outlook.

Download Report

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $293.72)
- $293.72 P/E (TTM): 24.16X Cap: $158.12B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $114.77)
- $114.77 P/E (TTM): 24.4X Cap: $142.40B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $210.60)
- $210.60 P/E (TTM): 89.53X Cap: $372.03B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $132.59)
- $132.59 P/E (TTM): 16.56X Cap: $230.76B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $304.35)
- $304.35 P/E (TTM): 16.54X Cap: $81.23B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $179.29)
- $179.29 P/E (TTM): 19.14X Cap: $431.79B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $92.71)
- $92.71 P/E (TTM): 25.24X Cap: $118.78B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $21.15)
- $21.15 P/E (TTM): 27.04X Cap: $1.51B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

Savaria Corporation (SIS $21.15)
- $21.15 P/E (TTM): 27.04X Cap: $1.51B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: Could you comment on the Q2, also do you feel the growth rate of Savaria is enough for share holders... is growth enough to drive share price higher?

Read Answer Asked by Harry on August 07, 2025

Savaria Corporation (SIS $21.15)
- $21.15 P/E (TTM): 27.04X Cap: $1.51B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: What does the market expect from Savaria tomorrow and with all the negativity towards healthcare should investors be concerned? Thx

Read Answer Asked by blake on August 05, 2025